Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

A Project to Improve Postpartum Depression Screening Practices Among Providers in a Community Women's Health Care Clinic.

Clevesy MA, Gatlin TK, Cheese C, Strebel K.

Nurs Womens Health. 2019 Feb;23(1):21-30. doi: 10.1016/j.nwh.2018.11.005. Epub 2019 Jan 1.

PMID:
30605631
2.

Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages.

Siddiqui R, Suzu S, Ueno M, Nasser H, Koba R, Bhuyan F, Noyori O, Hamidi S, Sheng G, Yasuda-Inoue M, Hishiki T, Sukegawa S, Miyagi E, Strebel K, Matsushita S, Shimotohno K, Ariumi Y.

PLoS Pathog. 2018 Nov 29;14(11):e1007372. doi: 10.1371/journal.ppat.1007372. eCollection 2018 Nov.

3.

HIV-1 Vpr and p21 restrict LINE-1 mobility.

Kawano K, Doucet AJ, Ueno M, Kariya R, An W, Marzetta F, Kuroki M, Turelli P, Sukegawa S, Okada S, Strebel K, Trono D, Ariumi Y.

Nucleic Acids Res. 2018 Sep 19;46(16):8454-8470. doi: 10.1093/nar/gky688.

4.

Is There a Relationship Between Gestational Diabetes and Perinatal Depression?

Clevesy MA, Gatlin TK, Strebel KT.

MCN Am J Matern Child Nurs. 2018 Jul/Aug;43(4):206-212. doi: 10.1097/NMC.0000000000000439.

PMID:
29958203
5.

Mannose Receptor 1 Restricts HIV Particle Release from Infected Macrophages.

Sukegawa S, Miyagi E, Bouamr F, Farkašová H, Strebel K.

Cell Rep. 2018 Jan 16;22(3):786-795. doi: 10.1016/j.celrep.2017.12.085.

6.

Professor Mark Wainberg.

Benkirane M, Berkhout B, Borrow P, Fassati A, Fujii M, Garcia JV, Gorry P, Lever A, Mak J, Nijhuis M, Strebel K, Venter F, Weiss R.

Retrovirology. 2017 May 5;14(1):30. doi: 10.1186/s12977-017-0353-6. No abstract available.

7.

Long-term passage of Vif-null HIV-1 in CD4+ T cells expressing sub-lethal levels of APOBEC proteins fails to develop APOBEC resistance.

Miyagi E, Kao S, Fumitaka M, Buckler-White A, Plishka R, Strebel K.

Virology. 2017 Apr;504:1-11. doi: 10.1016/j.virol.2017.01.016. Epub 2017 Jan 25.

8.

Pyviko: an automated Python tool to design gene knockouts in complex viruses with overlapping genes.

Taylor LJ, Strebel K.

BMC Microbiol. 2017 Jan 7;17(1):12. doi: 10.1186/s12866-016-0920-3.

9.

Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.

Chen CY, Shingai M, Welbourn S, Martin MA, Borrego P, Taveira N, Strebel K.

J Virol. 2016 Nov 28;90(24):11062-11074. Print 2016 Dec 15.

10.

Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Matsuda K, Chen CY, Whitted S, Chertova E, Roser DJ, Wu F, Plishka RJ, Ourmanov I, Buckler-White A, Lifson JD, Strebel K, Hirsch VM.

J Clin Invest. 2016 Jun 1;126(6):2295-307. doi: 10.1172/JCI83725. Epub 2016 May 9.

11.

Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1.

Welbourn S, Strebel K.

Virology. 2016 Jan 15;488:271-7. doi: 10.1016/j.virol.2015.11.022. Epub 2015 Dec 4.

12.

Fibrocytes Differ from Macrophages but Can Be Infected with HIV-1.

Hashimoto M, Nasser H, Bhuyan F, Kuse N, Satou Y, Harada S, Yoshimura K, Sakuragi J, Monde K, Maeda Y, Welbourn S, Strebel K, Abd El-Wahab EW, Miyazaki M, Hattori S, Chutiwitoonchai N, Hiyoshi M, Oka S, Takiguchi M, Suzu S.

J Immunol. 2015 Nov 1;195(9):4341-50. doi: 10.4049/jimmunol.1500955. Epub 2015 Sep 28.

13.

Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation.

Naisbitt DJ, Yang EL, Alhaidari M, Berry NG, Lawrenson AS, Farrell J, Martin P, Strebel K, Owen A, Pye M, French NS, Clarke SE, O'Neill PM, Park BK.

AIDS. 2015 Nov 28;29(18):2385-95. doi: 10.1097/QAD.0000000000000867.

PMID:
26372480
14.

Effect of Humira® on Intestinal Anastomotic Response in Rabbits.

Strebel K, Nielsen SR, Biagini M, Qvist N.

J Invest Surg. 2015 Jun;28(3):167-72. doi: 10.3109/08941939.2014.995244.

PMID:
26065592
15.

The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T Cells.

Shingai M, Welbourn S, Brenchley JM, Acharya P, Miyagi E, Plishka RJ, Buckler-White A, Kwong PD, Nishimura Y, Strebel K, Martin MA.

PLoS Pathog. 2015 May 21;11(5):e1004928. doi: 10.1371/journal.ppat.1004928. eCollection 2015 May.

16.

Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2.

Welbourn S, Kao S, Du Pont KE, Andrew AJ, Berndsen CE, Strebel K.

J Biol Chem. 2015 Feb 6;290(6):3740-51. doi: 10.1074/jbc.M114.617639. Epub 2014 Dec 18.

17.

Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA.

Klase Z, Yedavalli VS, Houzet L, Perkins M, Maldarelli F, Brenchley J, Strebel K, Liu P, Jeang KT.

PLoS Pathog. 2014 Mar 20;10(3):e1003997. doi: 10.1371/journal.ppat.1003997. eCollection 2014 Mar.

18.

CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.

Miyagi E, Kao S, Yedavalli V, Strebel K.

J Virol. 2014 May;88(9):4839-52. doi: 10.1128/JVI.03359-13. Epub 2014 Feb 12.

19.

HIV accessory proteins versus host restriction factors.

Strebel K.

Curr Opin Virol. 2013 Dec;3(6):692-9. doi: 10.1016/j.coviro.2013.08.004. Epub 2013 Nov 15. Review.

20.

HIV-1 accessory proteins: Vpu and Vif.

Andrew A, Strebel K.

Methods Mol Biol. 2014;1087:135-58. doi: 10.1007/978-1-62703-670-2_12.

21.

Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.

Yoshida T, Koyanagi Y, Strebel K.

J Virol. 2013 Dec;87(24):13825-36. doi: 10.1128/JVI.02567-13. Epub 2013 Oct 9.

22.

Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1.

Welbourn S, Dutta SM, Semmes OJ, Strebel K.

J Virol. 2013 Nov;87(21):11516-24. doi: 10.1128/JVI.01642-13. Epub 2013 Aug 21.

23.

HIV-1 Vpu - an ion channel in search of a job.

Strebel K.

Biochim Biophys Acta. 2014 Apr;1838(4):1074-81. doi: 10.1016/j.bbamem.2013.06.029. Epub 2013 Jul 3. Review.

24.

Emergence of gp120 V3 variants confers neutralization resistance in an R5 simian-human immunodeficiency virus-infected macaque elite neutralizer that targets the N332 glycan of the human immunodeficiency virus type 1 envelope glycoprotein.

Sadjadpour R, Donau OK, Shingai M, Buckler-White A, Kao S, Strebel K, Nishimura Y, Martin MA.

J Virol. 2013 Aug;87(15):8798-804. doi: 10.1128/JVI.00878-13. Epub 2013 May 29.

25.

Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G.

Gaur R, Strebel K.

PLoS One. 2012;7(11):e48850. doi: 10.1371/journal.pone.0048850. Epub 2012 Nov 26.

26.

The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release.

Andrew AJ, Berndsen CE, Kao S, Strebel K.

J Biol Chem. 2012 Dec 28;287(53):44278-88. doi: 10.1074/jbc.M112.418822. Epub 2012 Nov 14.

27.

Identification and characterization of naturally occurring splice variants of SAMHD1.

Welbourn S, Miyagi E, White TE, Diaz-Griffero F, Strebel K.

Retrovirology. 2012 Oct 23;9:86. doi: 10.1186/1742-4690-9-86.

28.

Hydrodynamic and functional analysis of HIV-1 Vif oligomerization.

Techtmann SM, Ghirlando R, Kao S, Strebel K, Maynard EL.

Biochemistry. 2012 Mar 13;51(10):2078-86. doi: 10.1021/bi201738a. Epub 2012 Mar 5.

29.

A noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytes.

Iijima S, Lee YJ, Ode H, Arold ST, Kimura N, Yokoyama M, Sato H, Tanaka Y, Strebel K, Akari H.

J Virol. 2012 Apr;86(7):3944-51. doi: 10.1128/JVI.06257-11. Epub 2012 Feb 1.

30.

C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.

Andrew AJ, Kao S, Strebel K.

J Biol Chem. 2011 Nov 18;286(46):39967-81. doi: 10.1074/jbc.M111.287011. Epub 2011 Sep 21.

31.

Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.

Miyagi E, Andrew A, Kao S, Yoshida T, Strebel K.

J Virol. 2011 Nov;85(22):11981-94. doi: 10.1128/JVI.05176-11. Epub 2011 Sep 14.

32.
33.

Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach.

Yoshida T, Kao S, Strebel K.

Front Microbiol. 2011 Feb 18;2:35. doi: 10.3389/fmicb.2011.00035. eCollection 2011.

34.

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin.

Andrew AJ, Miyagi E, Strebel K.

J Virol. 2011 Mar;85(6):2611-9. doi: 10.1128/JVI.02080-10. Epub 2010 Dec 29.

35.

The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?

Andrew A, Strebel K.

J Interferon Cytokine Res. 2011 Jan;31(1):137-44. doi: 10.1089/jir.2010.0108. Epub 2010 Dec 19. Review.

36.

Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility.

Kobayashi T, Ode H, Yoshida T, Sato K, Gee P, Yamamoto SP, Ebina H, Strebel K, Sato H, Koyanagi Y.

J Virol. 2011 Jan;85(2):932-45. doi: 10.1128/JVI.01668-10. Epub 2010 Nov 10.

37.

HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms.

Andrew A, Strebel K.

Mol Aspects Med. 2010 Oct;31(5):407-17. doi: 10.1016/j.mam.2010.08.002. Epub 2010 Sep 19. Review.

38.

Stably expressed APOBEC3F has negligible antiviral activity.

Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, Walker RC Jr, Hirsch V, Strebel K.

J Virol. 2010 Nov;84(21):11067-75. doi: 10.1128/JVI.01249-10. Epub 2010 Aug 11.

39.

Adaptive evolution of Mus Apobec3 includes retroviral insertion and positive selection at two clusters of residues flanking the substrate groove.

Sanville B, Dolan MA, Wollenberg K, Yan Y, Martin C, Yeung ML, Strebel K, Buckler-White A, Kozak CA.

PLoS Pathog. 2010 Jul 1;6:e1000974. doi: 10.1371/journal.ppat.1000974.

40.

A rigorous small area modelling-study for the Helicobacter pylori epidemiology.

Strebel K, Rolle-Kampczyk U, Richter M, Kindler A, Richter T, Schlink U.

Sci Total Environ. 2010 Aug 15;408(18):3931-42. doi: 10.1016/j.scitotenv.2010.03.045. Epub 2010 May 5.

PMID:
20444496
41.

Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps.

Magadán JG, Pérez-Victoria FJ, Sougrat R, Ye Y, Strebel K, Bonifacino JS.

PLoS Pathog. 2010 Apr 29;6(4):e1000869. doi: 10.1371/journal.ppat.1000869.

42.

Evaluation of human mobility models, for exposure to air pollutants.

Schlink U, Strebel K, Loos M, Tuchscherer R, Richter M, Lange T, Wernicke J, Ragas A.

Sci Total Environ. 2010 Aug 15;408(18):3918-30. doi: 10.1016/j.scitotenv.2010.03.018. Epub 2010 Apr 24.

PMID:
20417545
43.

Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.

Walker RC Jr, Khan MA, Kao S, Goila-Gaur R, Miyagi E, Strebel K.

J Virol. 2010 May;84(10):5201-11. doi: 10.1128/JVI.02318-09. Epub 2010 Mar 10.

44.

CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection.

Habermann A, Krijnse-Locker J, Oberwinkler H, Eckhardt M, Homann S, Andrew A, Strebel K, Kräusslich HG.

J Virol. 2010 May;84(9):4646-58. doi: 10.1128/JVI.02421-09. Epub 2010 Feb 10.

45.

Quantile regression of indoor air concentrations of volatile organic compounds (VOC).

Schlink U, Thiem A, Kohajda T, Richter M, Strebel K.

Sci Total Environ. 2010 Aug 15;408(18):3840-51. doi: 10.1016/j.scitotenv.2009.12.002. Epub 2010 Jan 6.

PMID:
20053420
46.

Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.

Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC Jr, Strebel K.

Retrovirology. 2009 Nov 3;6:99. doi: 10.1186/1742-4690-6-99.

47.

Human cellular restriction factors that target HIV-1 replication.

Strebel K, Luban J, Jeang KT.

BMC Med. 2009 Sep 16;7:48. doi: 10.1186/1741-7015-7-48. Review.

48.
49.

Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion.

Miyagi E, Andrew AJ, Kao S, Strebel K.

Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2868-73. doi: 10.1073/pnas.0813223106. Epub 2009 Feb 5.

50.

Differential sensitivity of "old" versus "new" APOBEC3G to human immunodeficiency virus type 1 vif.

Goila-Gaur R, Khan MA, Miyagi E, Strebel K.

J Virol. 2009 Jan;83(2):1156-60. doi: 10.1128/JVI.01734-08. Epub 2008 Nov 12.

Supplemental Content

Loading ...
Support Center